Evidence map›Paper›PMID 29953259›Full record

ArticleHuman gene therapy methods2018

Delineating the Cellular Mechanisms Associated with Skin Electroporation.

Katherine Schultheis, Trevor R F Smith, William B Kiosses, Kimberly A Kraynyak, Amelia Wong, Janet Oh, Kate E Broderick

Abstract read
In one paragraph

Article in Human gene therapy methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. DNA Vaccines-How Far From Clinical Use?International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Katherine Schultheis1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
Trevor R F Smith1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
William B Kiosses2 The Scripps Research Institute , Core Microscopy Facility, La Jolla, California.
Kimberly A Kraynyak1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
Amelia Wong1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
Janet Oh1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
Kate E Broderick1 Inovio Pharmaceuticals, Inc. , Plymouth Meeting, Pennsylvania.
Inovio Pharmaceuticals (United States) · USScripps Research Institute · US

Funding

Synthetic DNA & Novel Env Vaccine for HIVU19AI109646 · NIAID · WISTAR INSTITUTE · PI SARDESAI, NIRANJAN Y · 2015 to 2019
$16.7M
NIAID NIH HHS U19 AI109646
6 · The paper itself

Abstract

The immune responses elicited following delivery of DNA vaccines to the skin has previously been shown to be significantly enhanced by the addition of electroporation (EP) to the treatment protocol. Principally, EP increases the transfection of plasmid DNA (pDNA) into the resident skin cells. In addition to increasing the levels of in vivo transfection, the physical insult induced by EP is associated with activation of innate pathways which are believed to mediate an adjuvant effect, further enhancing DNA vaccine responses. We investigated the possible mechanisms associated with this adjuvant effect, primarily focusing on the cell death pathways associated with the skin EP procedure independent of pDNA delivery. Using the minimally invasive CELLECTRA

Indexed as

AnimalsApoptosisElectroporationFemaleGuinea PigsSkinVaccines, DNAVaccines, DNAapoptosiselectroporationnecrosisskin

Identifiers

PMID29953259
PMCPMC6421993
OpenAlexW2810793599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.